|
Market Closed -
Euronext Paris
11:55:00 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 37.10 EUR | +2.49% |
|
+1.23% | -13.82% |
| 09-09 | NEURONES Reaffirms Earnings Guidance for the Full Year of 2026 | CI |
| 09-09 | Neurones S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: NEURONES
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 920.3 | 950.8 | 1,062 | 1,067 | 1,047 | 864 | - | - |
| Change | - | 3.32% | 11.69% | 0.47% | -1.89% | -17.46% | - | - |
| Enterprise Value (EV) 1 | 655.7 | 679 | 771.5 | 747.4 | 710.1 | 532.9 | 500.2 | 462 |
| Change | - | 3.56% | 13.62% | -3.13% | -4.99% | -24.96% | -6.13% | -7.64% |
| P/E | 24.5x | 21.6x | 21.6x | 20.3x | 20.1x | 15.5x | 13.9x | 12.6x |
| PBR | 2.95x | 2.87x | 3x | 2.82x | 2.62x | 2.09x | 1.96x | 1.84x |
| PEG | - | 1.2x | 1.9x | 3.17x | -21.71x | 1.76x | 1.2x | 1.2x |
| Capitalization / Revenue | 1.59x | 1.43x | 1.43x | 1.32x | 1.22x | 0.94x | 0.89x | 0.85x |
| EV / Revenue | 1.13x | 1.02x | 1.04x | 0.92x | 0.83x | 0.58x | 0.51x | 0.45x |
| EV / EBITDA | 8.6x | 7.59x | 8.33x | 7.82x | 7.46x | 5.18x | 4.41x | 3.73x |
| EV / EBIT | 10.6x | 9.31x | 10.2x | 9.59x | 9.39x | 6.46x | 5.42x | 4.53x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1 | 1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Rate of return | 2.63% | 2.55% | 2.74% | 2.96% | 3.25% | 4.14% | 4.42% | 4.7% |
| EPS 2 | 1.55 | 1.82 | 2.03 | 2.16 | 2.14 | 2.329 | 2.598 | 2.869 |
| Distribution rate | 64.5% | 54.9% | 59.1% | 60.2% | 65.4% | 64.4% | 61.6% | 59.2% |
| Net sales 1 | 579.9 | 665.4 | 741.2 | 810.4 | 857.2 | 917.2 | 972.2 | 1,021 |
| EBITDA 1 | 76.28 | 89.44 | 92.61 | 95.58 | 95.14 | 103 | 113.5 | 123.9 |
| EBIT 1 | 61.6 | 72.9 | 75.9 | 77.9 | 75.6 | 82.55 | 92.36 | 102.1 |
| Net income 1 | 37.7 | 44.3 | 49.4 | 52.5 | 52.1 | 56.77 | 63.33 | 69.95 |
| Net Debt 1 | -264.6 | -271.8 | -290.4 | -319.5 | -336.6 | -331.1 | -363.8 | -402 |
| Reference price 2 | 38.00 | 39.25 | 43.75 | 43.95 | 43.05 | 36.20 | 36.20 | 36.20 |
| Nbr of stocks (in thousands) | 24,218 | 24,224 | 24,272 | 24,274 | 24,313 | 23,867 | - | - |
| Announcement Date | 2/9/22 | 2/8/23 | 3/6/24 | 3/5/25 | 3/11/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.54x | 0.58x | 5.18x | 4.14% | 991M | |
| 22.77x | 3.72x | 12.99x | 2.92% | 219B | |
| -133.08x | 18.57x | 102.94x | -.--% | 120B | |
| 13.79x | 1.52x | 8.01x | 3.47% | 114B | |
| 13.78x | 2.51x | 9.46x | 5.96% | 80.39B | |
| 19.36x | 5.14x | 12.63x | 2.93% | 57.92B | |
| 13.62x | 1.97x | 8.34x | 5.72% | 43.9B | |
| 22.36x | 1.83x | 11.42x | 1.31% | 43.83B | |
| 21.06x | 1.6x | 10.17x | 0.89% | 40.53B | |
| 17.65x | 2.23x | 10.58x | 4.95% | 36.18B | |
| Average | 2.69x | 3.97x | 19.17x | 3.23% | 75.58B | |
| Weighted average by Cap. | -5.37x | 5.32x | 25.44x | 2.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- NRO Stock
- Valuation NEURONES
Select your edition
All financial news and data tailored to specific country editions
